Effects of rutin on lipid profile in hypercholesterolaemic rats

Basic and Clinical Pharmacology and Toxicology

Volumn 104, Issue 3, 2009, Pages 253-258

  Ziaee, Amir ^b   Zamansoltani, Farzaneh ^b   Nassiri Asl, Marjan ^a,b   Abbasi, Esmail ^b  

^a Qazvin Metabolic Disease Research Centre   (Iran)

^b QAZVIN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CHOLESTEROL; FLAVONOL DERIVATIVE; HYPOCHOLESTEROLEMIC AGENT; LIPID; LIVER ENZYME; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MEVINOLIN; RUTOSIDE;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL DIET; CONTROLLED STUDY; CORRELATION ANALYSIS; DOSE RESPONSE; DRUG EFFECT; ENZYME ACTIVITY; HISTOPATHOLOGY; HYPERCHOLESTEROLEMIA; LIPID BLOOD LEVEL; LIVER WEIGHT; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; WISTAR RAT;

ANIMALS; ANTICHOLESTEREMIC AGENTS; CHOLESTEROL; CHOLESTEROL, DIETARY; CHOLESTEROL, LDL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; HYPERCHOLESTEROLEMIA; LIVER; LOVASTATIN; MALE; ORGAN SIZE; RATS; RATS, WISTAR; RUTIN;

ANIMALIA; MORUS (PLANT); RATTUS;

EID: 60349131232     PISSN: 17427835     EISSN: 17427843     Source Type: Journal    
DOI: 10.1111/j.1742-7843.2008.00368.x     Document Type: Article

References (40)

1. Loscalzo J, Libby P, Braunwald E. Disorder of cardiovascular disorders. In : Fauci AS, Braunwald E, Kasper DL, Hauser SL, Longo DL, Jameson JL et al. (eds). Harrison' s Principles of Internal Medicine. Mc Graw Hill Companies Inc, New York, 2008 1375, 1378, 1505.
2. Byington RP, Jukema JW, Salonen JT, Pitt B, Bruschke AV, Hoen H et al. Reduction in cardiovascular events during pravastatin therapy. Pooled analysis of clinical events of the pravastatin atherosclerosis intervention program. Circulation 1995 92 : 2419 25.
3. Delsing DJ, Offerman EH, van Duyvenvoorde W, van der Boom H, de Wit EC, Gijbels MJ et al. Acyl-CoA: cholesterol acyltransferase inhibitor avasimibe reduces atherosclerosis in addition to its cholesterol-lowering effect in ApoE*3-Leiden mice. Circulation 2001 103 : 1778 86.
4. Nofer JR, Kehrel B, Fobker M, Levkau B, Assmann G, von Eckardstein A. HDL and arteriosclerosis: beyond reverse cholesterol transport. Atherosclerosis 2002 161 : 1 16.
5. Bok SH, Lee SH, Park YB, Bae KH, Son KH, Jeong TS et al. Plasma and hepatic cholesterol and hepatic activities of 3-hydroxy-3-methyl-glutaryl-CoA reductase and acyl CoA: cholesterol transferase are lower in rats fed citrus peel extract or a mixture of citrus bioflavonoids. J Nutr 1999 129 : 1182 5.
6. Havsteen BH. The biochemistry and medical significance of the flavonoids. Pharmacol Ther 2002 96 : 67 202.
7. Arai Y, Watanabe S, Kimira M, Shimoi K, Mochizuki R, Kinae N. Dietary intakes of flavonols, flavones and isoflavones by Japanese women and the inverse correlation between quercetin intake and plasma LDL cholesterol concentration. J Nutr 2000 130 : 2243 50.
8. Kuntic V, Pejic N, Ivkovic B, Vujic Z, Ilic K, Micic S et al. Isocratic RP-HPLC method for rutin determination in solid oral dosage forms. J Pharm Biomed Anal 2007 43 : 718 21.
9. Schwedhelm E, Maas R, Troost R, Boger RH. Clinical pharmacokinetics of antioxidants and their impact on systemic oxidative stress. Clin Pharmacokinet 2003 42 : 437 59.
10. Sheu JR, Hsiao G, Chou PH, Shen MY, Chou DS. Mechanisms involved in the antiplatelet activity of rutin, a glycoside of the flavonol quercetin, in human platelets. J Agric Food Chem 2004 52 : 4414 18.
11. 4-induced hepatotoxicity in rodents. Fitoterapia 2002 73 : 557 63.
12. La Casa C, Villegas I, Alarcon de la Lastra C, Motilva V, Martin Calero MJ. Evidence for protective and antioxidant properties of rutin, a natural flavone, against ethanol induced gastric lesions. J Ethnopharmacol 2000 71 : 45 53.
13. Mellou F, Loutrari H, Stamatis H, Roussos C, Kolisis FN. Enzymatic esterification of flavonoids with unsaturated fatty acids: effect of the novel esters on vascular endothelial growth factor release from K562 cells. Process Biochem 2006 41 : 2029 34.
14. Trumbeckaite S, Bernatoniene J, Majiene D, Jakstas V, Savickas A, Toleikis A. The effect of flavonoids on rat heart mitochondrial function. Biomed Pharmacother 2006 60 : 245 8.
15. Nassiri-Asl M, Shariati-Rad S, Zamansoltani F. Anticonvulsive effects of intracerebroventricular administration of rutin in rats. Prog Neuro-Psychopharmacol Biol Psychiatry 2008 32 : 989 93.
16. Lebeau J, Neviere R, Cotelle N. Beneficial effects of different flavonoids on functional recovery after ischemia and reperfusion in isolated rat heart. Bioorg Med Chem Lett 2001 11 : 23 7.
17. De Celle T, Heeringa P, Strzelecka AE, Bast A, Smits JF, Janssen BJ. Sustained protective effects of 7-monohydroxyethylrutoside in an in vivo model of cardiac ischemia-reperfusion. Eur J Pharmacol 2004 494 : 205 12.
18. Gupta R, Singh M, Sharma A. Neuroprotective effect of antioxidants on ischaemia and reperfusion-induced cerebral injury. Pharmacol Res 2003 48 : 209 15.
19. Neumayer C, Fugl A, Nanobashvili J, Blumer R, Punz A, Gruber H et al. Combined enzymatic and antioxidative treatment reduces ischemia-reperfusion injury in rabbit skeletal muscle. J Surg Res 2006 133 : 150 8.
20. Katsube T, Imawaka N, Kawano Y, Yamazaki Y, Shiwaku K, Yamane Y. Antioxidant flavonol glycosides in mulberry (Morus alba L.) leaves isolated based on LDL antioxidant activity. Food Chem 2006 97 : 25 31.
21. Vogel HG, Vogel WH. Drug Discovery and Evaluation, Pharmacological Assay. Springer, Berlin, 1997 1096.
22. Jeon SM, Park YB, Choi MS. Antihypercholesterolemic property of naringin alters plasma and tissue lipids, cholesterol-regulating enzymes, fecal sterol and tissue morphology in rabbits. Clin Nut 2004 23 : 1025 34.
23. Moghadasian MH. Experimental atherosclerosis: a historical overview. Life Sci 2002 70 : 855 65.
24. Burstein PJ, Draznin B, Johnson CJ, Schalch DS. The effect of hypothyroidism on growth, serum growth hormone, the growth hormone-dependent somatomedin, insulin-like growth factor, and its carrier protein in rats. Endocrinology 1997 104 : 1107 11.
25. Choe S, Kim H, Jeong T, Bok S, Park Y. Naringin has an antiatherogenic effect with the inhibition of intercellular adhesion molecule-in hypercholesterolaemic rabbits. Cardiovasc Pharmacol 2001 38 : 947 55.
26. Kanhal MA, Ahmad F, Othman AA, Arif Z, Orf S, Murshed KS. Effects of pure and oxidized cholesterol-rich diet on some biochemical parameters in rats. Int J Food Nutr 2002 53 : 381 8.
27. Borradaile NM, Carroll KK, Kurowska EM. Regulation of HepG2 cell apolipoprotein B metabolism by the citrus flavanones hesperetin and naringenin. Lipids 1999 34 : 591 8.
28. Attaway JA, Buslig BS. Antithrombogenic and antiatherogenic effects of citrus flavonoids. Contributions of Ralph C. Robbins. Adv Exp Med Biol 1998 439 : 165 73.
29. Cervantes-Laurean D, Schramm DD, Jacobson EL, Halaweish I, Bruckner GG, Boissonneault GA. Inhibition of advanced glycation end product formation on collagen by rutin and its metabolites. J Nut Biochem 2006 17 : 531 40.
30. Bok SH, Park SY, Park YB, Lee MK, Jeon SM, Seong TS et al. Quercetin dihydrate and gallate supplements lower plasma and hepatic lipids and change activities of hepatic antioxidant enzymes in high cholesterol-fed rats. Int J Vitam Nutr Res 2002 72 : 161 9.
31. Becker EM, Ntouma G, Skibsted LH. Synergism and antagonism between quercetin and other chain-breaking antioxidants in lipid systems of increasing structural organization. Food Chem 2007 103 : 1288 96.
32. Middleton E Jr., Kandaswami C, Theoharides TC. The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer. Pharmacol Rev 2000 52 : 673 751.
33. Lopez-Revuelta A, Sanchez-Gallego JA, Hernandez-Hernandez A, Sanchez-Yague J, Llanillo M. Membrane cholesterol contents influence the protective effects of quercetin and rutin in erythrocytes damaged by oxidative stress. Chem Biol Interact 2006 161 : 79 91.
34. Kim H, Kong H, Choi B, Yang Y, Kim Y, Lim MJ et al. Metabolic and pharmacological properties of rutin, a dietary quercetin glycoside, for treatment of inflammatory bowel disease. Pharma Res 2005 22 : 1499 509.
35. Kwon KH, Murakami A, Tanaka T, Ohigashi H. Dietary rutin, but not its aglycone quercetin, ameliorates dextran sulfate sodium-induced experimental colitis in mice: attenuation of proinflammatory gene expression. Biochem Pharmacol 2005 69 : 395 406.
36. Rotelli AE, Guardia T, Juárez AO, de la Rocha NE, Pelzer LE. Comparative study of flavonoids in experimental models of inflammation. Pharmacol Res 2003 48 : 601 606.
37. Farmer JA. Aggressive lipid therapy in the statin era. Prog Cardiovas Dis 1998 41 : 71 94.
38. Iseri S, Ercan F, Gedik N, Yuksel M, Alican I. Simvastatin attenuates cisplatin-induced kidney and liver damage in rats. Toxicology 2007 230 : 256 64.
39. Asahi M, Huang Z, Thomas S, Yoshimura S, Sumii T, Mori T et al. Protective effects of statins involving both eNOS and tPA in focal cerebral ischemia. J Cereb Blood Flow Metab 2005 25 : 722 9.
40. Stanislaus R, Pahan K, Singh AK, Singh I. Amelioration of experimental allergic encephalomyelitis in Lewis rats by lovastatin. Neurosci Lett 1999 269 : 71 4.